Full Press Release Details
Precipio announces shareholder update
call on commercial progress
Conference call to be held Thursday October
NEW HAVEN, CT, (October 2, 2019) -
Specialty diagnostics company Precipio, Inc. (NASDAQ:
PRPO), will hold a shareholder update call where CEO Ilan Danieli will discuss the company's commercial progress.
conference call may be accessed by calling 1-844-695-5519 (international
callers may dial 1-412-902-6760). All
callers should ask for the Precipio Inc. conference call. Participants may also pre-register for
the conference call at http://dpregister.com/10135623 and
will receive a calendar invite and a direct dial-in number, bypassing the operator.
Precipio has built a platform designed
to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions
and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class
academic institutions specializing in cancer research, diagnostics and treatment such as the Yale School of Medicine and Harvard's
Dana-Farber Cancer Institute, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care.
For more information, please visit www.precipiodx.com.
Forward-Looking Statements
Certain statements in this press release
constitute "forward-looking statements," within the meaning of federal securities laws, including statements related
to ICP technology, including financial projections related thereto and potential market opportunity, plans and prospects and other
statements containing the words "anticipate," "intend," "may," "plan," "predict,"
"will," "would," "could," "should," and similar expressions, constitute forward-looking
statements within the meaning of The Private Securities Litigation Reform Act of 1995. The Company's actual results could differ
materially from those anticipated in these forward-looking statements as a result of various factors. Factors that could cause
future results to materially differ from the recent results or those projected in forward-looking statements include the known
risks, uncertainties and other factors described in the Company's definitive proxy statement filed on April 19, 2019 , the
Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2019 and on the Annual Report on Form 10-K for the
year ended December 31, 2018 as well as the Company's prior filings and from time to time in the Company's subsequent
filings with the Securities and Exchange Commission. Any change in such factors, risks and uncertainties may cause the actual results,
events and performance to differ materially from those referred to in such statements. All information in this press release is
as of the date of the release and the Company does not undertake any duty to update this information, including any forward-looking
statements, unless required by law.